Liquid chromatographic determination of pinacidil, a new antihypertensive drug, and its major metabolite, pinacidil N-oxide, in plasma.

[1]  T. Kardel,et al.  Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension , 1985, Clinical pharmacology and therapeutics.

[2]  J. W. Ward.  Pinacidil monotherapy for hypertension. , 1984, British journal of clinical pharmacology.

[3]  L. Ramsay,et al.  Preliminary evaluation of pinacidil in hypertension. , 1983, British journal of clinical pharmacology.

[4]  U. B. Olsen,et al.  Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent. , 1983, European journal of pharmacology.

[5]  P. Timmermans,et al.  Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine. , 1983, Pharmacology.

[6]  E. Eilertsen,et al.  Metabolism of the new antihypertensive agent pinacidil in rat, dog and man. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  E. Eilertsen,et al.  Pharmacokinetics and distribution of the new antihypertensive agent pinacidil in rat, dog and man. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  T. Kardel,et al.  N-N-Cyano--4‐pyridyl-N'-1,2,2‐trimethyl-propylguanidine, a New Vasodilating Agent: Acute Effect on Blood Pressure and Pharmacokinetics in Hypertensive Patients , 1981, Journal of cardiovascular pharmacology.